Stock

CytomX Therapeutics, Inc. CTMX

$3.24-3.14%

All stocks Create account to unlock

Overview

CTMX market data

Price History

CTMX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for CTMX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

4 captured

8-K filing — CytomX Therapeutics, Inc. (CTMX) · Jun 22, 2026, 8:52 PM

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer · Jun 3, 2026, 12:15 PM

CytomX Therapeutics to Present at Upcoming June Investor Conferences · May 21, 2026, 12:15 PM

HC Wainwright & Co. Maintains Buy on CytomX Therapeutics, Lowers Price Target to $11 · May 11, 2026, 11:24 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock